Company Filing History:
Years Active: 2018
Title: Mark Pitts - Innovator in Biomarker Detection
Introduction
Mark Pitts is a notable inventor based in Gwynedd, GB. He has made significant contributions to the field of biomarker detection, showcasing his innovative spirit through his patented methods. His work is particularly relevant in the medical and diagnostic sectors, where accurate detection of biomarkers can lead to improved health outcomes.
Latest Patents
Mark Pitts holds a patent for a method for determining the presence or absence of a biomarker. This method involves several steps: linking an antigen to colloidal gold to create a gold-antigen species, contacting this species with a sample, adding a diagnostic agent to the sample, and finally observing the color of the sample. This innovative approach enhances the accuracy and efficiency of biomarker detection.
Career Highlights
Mark Pitts is associated with Arcis Biotechnology Holdings Limited, a company that focuses on advancing biotechnology solutions. His work at Arcis has allowed him to apply his inventive ideas in a practical setting, contributing to the company's mission of improving diagnostic technologies.
Collaborations
Mark has collaborated with notable colleagues, including Christopher David Gwenin and Mark Stephen Baird. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Mark Pitts exemplifies the spirit of innovation in the field of biomarker detection. His contributions through patents and collaborations highlight the importance of creativity in advancing medical diagnostics.